Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Spatially mapping the tumour immune microenvironments of non-small cell lung cancer

4 Feb 2025

Abstract excerpt

Lung cancer is the leading cause of cancer-related deaths. An enhanced understanding of the immune microenvironments within these tumours may foster more precise and efficient treatment, particularly for immune-targeted therapies. The spatial architectural differences between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are relatively unexplored. Here, we applied imaging mass cytometry to a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune cells in cancer
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39905080
DOI: 10.1038/s41467-025-56546-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Spatially mapping the tumour immune microenvironments of non-small cell lung cancerPMID 39905080Read ↗

Novel Spatial Approaches to Dissect the Lung Cancer Immune MicroenvironmentSemantic proximity Read ↗

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerSemantic proximity Read ↗

Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerSemantic proximity Read ↗

Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy responseSemantic proximity Read ↗

Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerSemantic proximity Read ↗

Spatially Organized Tertiary Lymphoid Structures Emerge in Small Cell Lung Cancer and Associate with Improved SurvivalSemantic proximity Read ↗

Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 ExpressionSemantic proximity Read ↗

Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.Semantic proximity Read ↗

Spatiotemporal Profiling Unveiling the Cellular Organization Patterns and Local Protumoral Immune Microenvironment Remodeling in Early Lung Adenocarcinoma ProgressionSemantic proximity Read ↗

Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung AdenocarcinomaSemantic proximity Read ↗

Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and ProgressionSemantic proximity Read ↗

Transcriptional states of lung cancer microenvironment reveal macrophage subtype dynamics linked to disease progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.